Skip NavigationSkip to Content

Phospho-azatyrosine, a less effective protein-tyrosine phosphatase substrate than phosphotyrosine

  1. Author:
    Burke, T. R.
    Yao, Z. J.
    Ye, B.
    Miyoshi, K.
    Otaka, A.
    Wu, L.
    Zhang, Z. Y.
  2. Author Address

    NCI, Med Chem Lab, Div Basic Sci, NIH, FCRDC, Bldg 376, Boyles St, POB B, Frederick, MD 21702 USA. NCI, Med Chem Lab, Div Basic Sci, NIH, FCRDC, Frederick, MD 21702 USA. Kyoto Univ, Fac Pharmaceut Sci, Sakyo Ku, Kyoto 606, Japan. Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.
    1. Year: 2001
  1. Journal: Bioorganic & Medicinal Chemistry Letters
    1. 11
    2. 10
    3. Pages: 1265-1268
  2. Type of Article: Article
  1. Abstract:

    Azatyrosine (AzaTyr, 4) is a natural product isolated from Streptomyces chihanesis, whose structure is characterized by a nitrogen atom in the aryl ring of a tyrosyl residue. This seemingly minor modification to the tyrosyl residue results in profound physiological effects, as AzaTyr has been shown to promote permanent reversion of ras-dependent transformed cells to the normal phenotype in culture and to inhibit chemical induction of carcinogenesis in transgenic mice bearing oncogenic human ras. The mechanisms underlying these effects are not known, however ras-pathways involve an intricate balance between both protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs). The present study was undertaken to examine the general utility of AzaTyr as a structural motif for PTP inhibitor design by examining the phospho-azatyrosine (pAzaTyr)-containing peptide Ac-Asp-Ala- Asp-Glu-pAzaTyr-Leu-amide (8) in a PTP1 enzyme system. Kinetic analysis indicated that 8 binds with a K-m value of 210 muM and a catalytic turnover rate, k(cat) of 52 s(-1). This represents a greater than 50-fold reduction in binding affinity relative to the parent phosphotyrosine-containing peptide, indicating that the aryl nitrogen adversely affects binding affinity. The much lower PTP affinity of the pAzaTyr-containing peptide reduces the potential utility of the AzaTyr pharmacophore for PTP inhibitor design. These results are discussed from the point of view that incorporation of AzaTyr residues into proteins could result in perturbation of protein-tyrosine phosphorylation/dephosphorylation cascades that control signal transduction processes, including,as-dependent pathways. Published by Elsevier Science Ltd.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel